Tipranavir Expanded Access Program (EAP)
Expanded access is no longer available for this treatment.
Sponsor:
Boehringer Ingelheim Pharmaceuticals
Information provided by (Responsible Party):
Boehringer Ingelheim Pharmaceuticals
ClinicalTrials.gov Identifier:
NCT00097799
First received: November 30, 2004
Last updated: June 25, 2012
Last verified: June 2012
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | Expanded access is no longer available for this treatment. |
|---|---|
| Estimated Study Completion Date: | No date given |
| Primary Completion Date: | August 2005 (Final data collection date for primary outcome measure) |